Halozyme Therapeutics, Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 97.72%92.77%99.54%97.42%88.60%69.83%78.35%77.36%90.16%93.33%76.76%83.79%81.64%78.90%76.80%84.30%
EBT Margin -426.88%-390.79%-35.25%-126.53%-152.34%-90.76%-23.86%-69.44%19.46%-52.54%-36.86%48.32%56.06%37.71%42.01%54.87%
EBIT Margin -427.60%-398.25%-35.37%-126.70%-146.78%-83.68%-20.33%-56.72%25.58%-45.65%-34.50%53.91%62.24%40.53%40.71%54.32%
EBITDA Margin -427.60%-398.25%-35.37%-126.70%-146.78%-83.68%-20.33%-56.72%25.58%-45.65%-34.50%53.91%62.24%40.53%40.71%54.32%
Operating Margin -427.60%-398.25%-35.37%-126.70%-146.78%-83.68%-20.33%-56.72%25.58%-45.65%-34.50%53.91%62.24%40.53%40.71%54.32%
Net Margin -426.88%-390.79%-35.25%-126.53%-152.34%-90.76%-23.86%-70.23%19.89%-52.90%-36.86%48.24%90.84%30.62%33.96%43.74%
FCF Margin -304.35%-337.87%-62.63%-155.21%-94.23%-64.89%-29.20%-36.48%41.91%-35.67%-45.65%19.79%67.22%35.43%45.01%46.13%
Efficiency
Inventory Average 0.80M0.68M0.38M1.62M4.42M6.29M7.95M12.06M9.88M13.89M25.99M45.05M57.33M77.02M113.86M134.73M
Assets Average 76.86M84.25M78.55M100.24M118.26M133.88M173.88M221.65M390.73M480.10M503.06M572.90M842.18M1,472.97M1,787.39M1,898.37M
Equity Average 11.14M13.63M15.63M29.88M14.43M10.68M42.18M5.26M87.94M228.63M170.33M121.41M174.00M183.38M126.80M223.81M
Invested Capital 6.90M20.35M10.90M78.52M29.78M91.21M70.97M166.75M333.51M283.76M474.81M548.27M984.21M1,675.90M1,583.06M1,869.62M
Asset Utilization Ratio 0.180.160.710.420.460.560.780.660.810.320.390.470.530.450.460.53
Leverage & Solvency
Interest Coverage Ratio -24.57-11.29-5.28-4.173.68-3.84-5.817.0836.6615.7917.9930.48
Debt to Equity 0.610.51-0.540.370.370.212.634.458.8717.894.14
Debt Ratio 0.220.120.070.150.210.030.680.790.820.860.73
Equity Ratio 0.090.220.170.36-0.200.250.24-0.120.400.570.160.260.180.090.050.18
Times Interest Earned -24.57-11.29-5.28-4.173.68-3.84-5.817.0836.6615.7917.9930.48
Valuation
Enterprise Value 470.50M712.69M933.73M656.75M1,637.79M1,074.36M2,110.14M1,074.38M2,414.94M1,760.35M2,176.88M5,405.65M4,920.12M7,330.83M4,546.35M5,486.65M
Market Capitalization 537.97M795.44M986.11M756.25M1,709.29M1,209.99M2,218.48M1,279.36M2,884.15M2,114.88M2,598.15M5,773.67M5,661.05M7,693.62M4,882.35M6,082.72M
Return Ratios
Return on Sales -4.27%-3.91%-0.35%-1.27%-1.52%-0.91%-0.24%-0.70%0.20%-0.53%-0.37%0.48%0.91%0.31%0.34%0.44%
Return on Capital Employed -0.94%-0.79%-0.32%-0.66%-0.86%-0.58%-0.25%-0.50%0.31%-0.21%-0.16%0.95%0.38%0.20%0.20%0.31%
Return on Invested Capital -0.18%0.28%0.16%0.17%0.25%
Return on Assets -0.76%-0.63%-0.25%-0.53%-0.71%-0.51%-0.19%-0.46%0.16%-0.17%-0.14%0.23%0.48%0.14%0.16%0.23%
Return on Equity -5.24%-3.91%-1.27%-1.79%-5.78%-6.40%-0.76%-19.59%0.72%-0.35%-0.42%1.06%2.31%1.10%2.22%1.98%